Bischof et al., 2006 - Google Patents
Implantation of the Human Embryo: Research Lines and Models: From the Implantation Research Network 'Fruitful'Bischof et al., 2006
View PDF- Document ID
- 16970596488942542187
- Author
- Bischof P
- Aplin J
- Bentin-Ley U
- Brannstrom M
- Casslén B
- Castrillo J
- Classen-Linke I
- Critchley H
- Devoto L
- D’Hooghe T
- Horcajadas J
- Groothuis P
- Ivell R
- Pongrantz I
- Macklon N
- Sharkey A
- Vicovac L
- White J
- Winterhager E
- Von Wolff M
- Simon C
- Stavreus-Evers A
- Publication year
- Publication venue
- Gynecologic and obstetric investigation
External Links
Snippet
Infertility is an increasing problem all over the world, and it has been estimated that 10–15% of couples in fertile age have fertility problems. Likewise induced unsafe abortion is a serious threat to women's health. Despite advances made in assisted reproduction …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ata et al. | Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses | |
US6309843B1 (en) | Glycoprotein for use in determining endometrial receptivity | |
Simón et al. | Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium | |
Gellersen et al. | Non-genomic progesterone actions in female reproduction | |
Dimitriadis et al. | Interleukin-11, IL-11 receptorα and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window | |
Deryabin et al. | The link between endometrial stromal cell senescence and decidualization in female fertility: the art of balance | |
Strug et al. | RBPJ mediates uterine repair in the mouse and is reduced in women with recurrent pregnancy loss | |
Bischof et al. | Implantation of the Human Embryo: Research Lines and Models: From the Implantation Research Network ‘Fruitful’ | |
RU2617515C1 (en) | Method for endometry receivability prediction based on evaluation of gnrg and gnrgr expression in "implantation window" for women infertility endometry and ivf program failure attempts | |
Moons et al. | Intact follicular maturation and defective luteal function in mice deficient for cyclin-dependent kinase-4 | |
Makker et al. | Effect of ormeloxifene, a selective estrogen receptor modulator, on biomarkers of endometrial receptivity and pinopode development and its relation to fertility and infertility in Indian subjects | |
Vassena et al. | Menstrual cycle length in reproductive age women is an indicator of oocyte quality and a candidate marker of ovarian reserve | |
Yang et al. | Exploration of the value of progesterone and progesterone/estradiol ratio on the hCG trigger day in predicting pregnancy outcomes of PCOS patients undergoing IVF/ICSI: a retrospective cohort study | |
Salamonsen et al. | Genes involved in implantation | |
RU2724381C1 (en) | Method for assessing endometrial receptiveness in endometriosis-associated infertility | |
Molina et al. | Luteal cytoplasmic estradiol and progesterone receptors in human endometrium: in vitro fertilization and normal cycles | |
Tola et al. | Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome | |
Lim et al. | A critical role for adiponectin‐mediated development of endometrial luminal epithelial cells during the peri‐implantation period of pregnancy | |
Varlı et al. | Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome | |
Mohamet et al. | Determining the LIF-sensitive period for implantation using a LIF-receptor antagonist | |
Gremlich et al. | LIF and sIL-2R plasma concentrations in IVF patients on the day of embryo transfer: predictive markers of IVF outcome | |
Cai et al. | Intrauterine infusion of human chorionic gonadotropin improves the endometrial FoxP3+ Tregs level and pregnancy outcomes in patients with lower endometrial FoxP3+ Tregs | |
Kohnen et al. | Endothelin receptor expression in human decidua. | |
JP2002519640A (en) | Assays to indicate the presence of unfertilized eggs | |
Ferguson II et al. | Expression and specific immunolocalization of the human parathyroid hormone/parathyroid hormone–related protein receptor in the uteroplacental unit |